Streetbeat News

Outset Medical, Inc.

https://www.outsetmedical.com

Industry

Medical - Devices

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Open

0.72

Mkt cap

39M

Volume

1.2M

High

0.77

P/E Ratio

-0.30

52-wk high

5.22

Low

0.68

Div yield

N/A

52-wk low

0.43

Outset Medical (OM) is showing signs of a potential trend reversal with a hammer chart pattern and upward earnings estimate revisions, suggesting it may be a good time to buy.

Portfolio Pulse from

February 26, 2025 | 4:15 pm

The article discusses how Bitcoin has underperformed expectations in 2025, despite reaching $100,000 in December. It suggests that there may be better cryptocurrency investment options than Bitcoin at the moment.

Portfolio Pulse from

February 26, 2025 | 1:45 pm

Outset Medical, Inc. held its Q4 2024 earnings call, discussing financial results and company performance. Key participants included CEO Leslie Trigg and CFO Nabeel Ahmed.

Portfolio Pulse from

February 20, 2025 | 2:15 am

Outset Medical reported fourth-quarter earnings that exceeded analysts' expectations, with revenue reaching $29.5 million against a forecast of $28 million. This indicates strong revenue growth despite market challenges.

Portfolio Pulse from

February 19, 2025 | 11:45 pm

Outset Medical, Inc. (OM) reported a Q4 loss of $0.37 per share, which was better than the Zacks Consensus Estimate of a $0.43 loss. This is an improvement from the $0.59 loss per share a year ago.

Portfolio Pulse from

February 19, 2025 | 11:30 pm

Outset Medical, Inc. (Nasdaq: OM) reported its financial results for Q4 and full year 2024, highlighting its innovative dialysis technology.

Portfolio Pulse from

February 19, 2025 | 9:30 pm

Outset Medical, Inc. (OM) is expected to report negative earnings in its upcoming release. The company lacks the key ingredients for an earnings beat, indicating potential challenges ahead.

Portfolio Pulse from

February 12, 2025 | 4:15 pm

Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Outset Medical, Inc. (NASDAQ: OM).

Portfolio Pulse from

February 06, 2025 | 11:00 pm

Outset Medical, Inc. (Nasdaq: OM) will release its Q4 and full-year 2024 financial results on February 19, 2025. The company is known for its innovative dialysis technology.

Portfolio Pulse from

February 03, 2025 | 2:15 pm

Outset Medical has announced a $169 million private placement financing from mutual funds and healthcare institutional investors. Additionally, the company has secured new debt financing of up to $125 million maturing in 2030, with plans to retire $200 million in prior debt.

Portfolio Pulse from

January 06, 2025 | 1:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.